Fulya Oz Puyan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fulya Oz Puyan has a total of 275 co-authors. Here are the top co-authors by number of shared publications:
Ebru Tastekin
Trakya Univ, Fac Med, Dept Pathol, Balkan Campus, TR-22030 Edirne, Turkey
11 shared publicationsMurat Caloglu
8 shared publicationsNecdet Sut
Trakya Univ, Fac Med, Dept Biostat, Balkan Campus, Edirne, Turkey
6 shared publications- Nuray Can
Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey
6 shared publications - Ahmet Muzaffer Demir
Trakya Universitesi, Tip Fakultesi
5 shared publications Filiz Ozyilmaz
Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey
5 shared publications
Latest Publications
- 11 July 2026
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 26 (9) , e1069-e1076.e2
Clonal Hematopoiesis in Newly Diagnosed Multiple Myeloma: Associations with Neutropenia, Supportive Care Burden and Survival
- 11 July 2026
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 26 (9) , e1069-e1076.e2
Clonal Hematopoiesis in Newly Diagnosed Multiple Myeloma: Associations with Neutropenia, Supportive Care Burden and Survival
- 27 April 2026
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 48 (4) , 848-855
Clinical Impact of Next‐Generation Sequencing–Detected Mutations on Thrombotic Events in Myeloproliferative Neoplasms
Introduction: Myeloproliferative neoplasms (MPNs), encompassing polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are hematologic malignancies characterized by recurrent somatic mutations. Despite advances in next‐generation sequencing (NGS), the genetic basis of thrombotic risk and bone marrow (BM) fibrosis in MPNs remains unclear. Methods: Patients diagnosed with classical MPN at Trakya University Faculty of Medicine were retrospectively analyzed (2018–2025). Mutation profiling was conducted on BM aspirates using a 78‐gene panel on the Illumina NextSeq platform, with clinically relevant variants (VAF ≥ 2%) interpreted via Qiagen Clinical Insight. Results: Among 91 patients with MPN, the most frequent mutations were JAK2 (71.4%), TET2 (23.1%), DNMT3A (15.4%), ASXL1 (11%), and splicing factor mutations (SFMs; 12%). Arterial events occurred in 45.1% of patients and were associated with age ( p < 0.001), higher Charlson Comorbidity Index (CCI; p < 0.001), ASXL1 (p:0.019), and SFMs (p:0.009). VTE occurred in 38.5% and was associated with JAK2 status and allele burden (p:0.004 and p:0.012 respectively), TET2 ( p < 0.001), and SFMs (p:0.002); the JAK2/TET2 co‐mutant subgroup had the highest risk of VTE risk in multivariable analysis (OR: 2.9, 95% CI: 1.4–5.7; p:0.002). Advanced BM fibrosis was associated with SFMs (p:0.018). Increased mutational burden correlated with both venous and arterial thrombosis (p:0.021 and p:0.044, respectively). In survival analyses, SFMs (HR: 5.2; p:0.008), ASXL1 (HR: 3.8; p:0.030), and PMF diagnosis (HR: 3.8; p:0.045) were associated with inferior overall survival (OS). Conclusion: Molecular profiling may provide clinically relevant thrombotic risk stratification in classical MPNs. JAK2/TET2 co‐mutation was linked to VTE, while ASXL1 and SFMs were associated with adverse phenotypes including vascular events, BM fibrosis, and inferior OS.
- 27 April 2026
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 48 (4) , 848-855
Clinical Impact of Next‐Generation Sequencing–Detected Mutations on Thrombotic Events in Myeloproliferative Neoplasms
Introduction: Myeloproliferative neoplasms (MPNs), encompassing polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are hematologic malignancies characterized by recurrent somatic mutations. Despite advances in next‐generation sequencing (NGS), the genetic basis of thrombotic risk and bone marrow (BM) fibrosis in MPNs remains unclear. Methods: Patients diagnosed with classical MPN at Trakya University Faculty of Medicine were retrospectively analyzed (2018–2025). Mutation profiling was conducted on BM aspirates using a 78‐gene panel on the Illumina NextSeq platform, with clinically relevant variants (VAF ≥ 2%) interpreted via Qiagen Clinical Insight. Results: Among 91 patients with MPN, the most frequent mutations were JAK2 (71.4%), TET2 (23.1%), DNMT3A (15.4%), ASXL1 (11%), and splicing factor mutations (SFMs; 12%). Arterial events occurred in 45.1% of patients and were associated with age ( p < 0.001), higher Charlson Comorbidity Index (CCI; p < 0.001), ASXL1 (p:0.019), and SFMs (p:0.009). VTE occurred in 38.5% and was associated with JAK2 status and allele burden (p:0.004 and p:0.012 respectively), TET2 ( p < 0.001), and SFMs (p:0.002); the JAK2/TET2 co‐mutant subgroup had the highest risk of VTE risk in multivariable analysis (OR: 2.9, 95% CI: 1.4–5.7; p:0.002). Advanced BM fibrosis was associated with SFMs (p:0.018). Increased mutational burden correlated with both venous and arterial thrombosis (p:0.021 and p:0.044, respectively). In survival analyses, SFMs (HR: 5.2; p:0.008), ASXL1 (HR: 3.8; p:0.030), and PMF diagnosis (HR: 3.8; p:0.045) were associated with inferior overall survival (OS). Conclusion: Molecular profiling may provide clinically relevant thrombotic risk stratification in classical MPNs. JAK2/TET2 co‐mutation was linked to VTE, while ASXL1 and SFMs were associated with adverse phenotypes including vascular events, BM fibrosis, and inferior OS.
- Open Access
- 11 January 2026
- Published by Wiley in Journal of Experimental Orthopaedics
- Vol. 13 (1)
Comparative effects of bone marrow stimulation and shockwave therapy on rotator cuff healing in chronic massive rotator cuff tears: A rat model study
Purpose: Surgical intervention for massive rotator cuff tear (MRCT) has been found to result in positive outcomes; however, a high retear rate has frequently been reported. The present study employed a chronic MRCT model to assess the impact of microdrilling, a bone marrow stimulation (BMS) technique and extracorporeal shockwave therapy (ESWT) on rotator cuff healing. We hypothesized that BMS would result in superior healing than ESWT, reflected by a more normal tendon‐to‐bone junction histomorphology. Methods: A chronic rotator cuff tear model was created in the supraspinatus and infraspinatus tendons of 30 Sprague–Dawley rats. Four weeks later, the tendons were repaired using the transosseous technique. The animals were randomly assigned to three groups. In Group I, the intervention consisted exclusively of tendon repair. In Group II, ESWT was administered at various time points in conjunction with the repair process. In Group III, microdrilling was performed prior to the initiation of repairs. The animals were euthanized at 4 and 8 weeks post‐repair. Repaired tendons, specifically the tendon‐to‐bone junction, were evaluated histomorphologically using the Bonar score and immunohistochemically for CD34, bone morphogenetic protein‐2 (BMP‐2), bone morphogenetic protein‐7 (BMP‐7) and transforming growth factor‐β1 (TGF‐β1). Results: A lower Bonar scale score in Group III more closely resembled normal tissue with respect to tenocyte morphology, extracellular matrix composition and vascularity, although statistical significance was limited to vascularity and extracellular matrix composition. By contrast, Group II showed a significant time‐dependent deterioration in tenocyte morphology. Group III exhibited elevated BMP‐2 and BMP‐7 expression levels, and an increase in CD34 at the tendon‐to‐bone junction was observed in Group II; however, these did not reach statistical significance. TGF‐β1 expression remained comparable among all groups. Conclusions: Both biological augmentation with BMS and ESWT demonstrated beneficial effects on tendon‐to‐bone healing in a rat model of chronic MRCT; however, these effects were not statistically significant. Although increased BMP‐2, BMP‐7 and CD34 expressions were noted in Group III, significant improvements were noted in vascularity according to the Bonar scale score, along with early enhancements in ground substance and overall histological structure. The deterioration of tenocyte morphology in the ESWT group highlights the need for optimized energy parameters. Level of Evidence: N/A.
- 11 January 2026
- Published by Wiley in Journal of Experimental Orthopaedics
- Vol. 13 (1)
Open AccessComparative effects of bone marrow stimulation and shockwave therapy on rotator cuff healing in chronic massive rotator cuff tears: A rat model study
Purpose: Surgical intervention for massive rotator cuff tear (MRCT) has been found to result in positive outcomes; however, a high retear rate has frequently been reported. The present study employed a chronic MRCT model to assess the impact of microdrilling, a bone marrow stimulation (BMS) technique and extracorporeal shockwave therapy (ESWT) on rotator cuff healing. We hypothesized that BMS would result in superior healing than ESWT, reflected by a more normal tendon‐to‐bone junction histomorphology. Methods: A chronic rotator cuff tear model was created in the supraspinatus and infraspinatus tendons of 30 Sprague–Dawley rats. Four weeks later, the tendons were repaired using the transosseous technique. The animals were randomly assigned to three groups. In Group I, the intervention consisted exclusively of tendon repair. In Group II, ESWT was administered at various time points in conjunction with the repair process. In Group III, microdrilling was performed prior to the initiation of repairs. The animals were euthanized at 4 and 8 weeks post‐repair. Repaired tendons, specifically the tendon‐to‐bone junction, were evaluated histomorphologically using the Bonar score and immunohistochemically for CD34, bone morphogenetic protein‐2 (BMP‐2), bone morphogenetic protein‐7 (BMP‐7) and transforming growth factor‐β1 (TGF‐β1). Results: A lower Bonar scale score in Group III more closely resembled normal tissue with respect to tenocyte morphology, extracellular matrix composition and vascularity, although statistical significance was limited to vascularity and extracellular matrix composition. By contrast, Group II showed a significant time‐dependent deterioration in tenocyte morphology. Group III exhibited elevated BMP‐2 and BMP‐7 expression levels, and an increase in CD34 at the tendon‐to‐bone junction was observed in Group II; however, these did not reach statistical significance. TGF‐β1 expression remained comparable among all groups. Conclusions: Both biological augmentation with BMS and ESWT demonstrated beneficial effects on tendon‐to‐bone healing in a rat model of chronic MRCT; however, these effects were not statistically significant. Although increased BMP‐2, BMP‐7 and CD34 expressions were noted in Group III, significant improvements were noted in vascularity according to the Bonar scale score, along with early enhancements in ground substance and overall histological structure. The deterioration of tenocyte morphology in the ESWT group highlights the need for optimized energy parameters. Level of Evidence: N/A.
- Open Access
- 23 June 2025
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 26 (2) , 136-143
Gastrointestinal Manifestations of Mature B Cell Neoplasms: Single Center Experiences from the Collective Perspective of Hematology and Pathology
Background/aim: Hematological malignancies frequently affect the gastrointestinal (GI) tract, either by secondary extranodal or extramedullary extension to the GI tract or as the primary process, developing in the GI tract. The prevalence of gastrointestinal non-Hodgkin’s lymphomas (gNHL) is smaller than other solid organ tumours of the GI tract. Therefore, in the absence of nodal or extranodal involvement in imaging methods, difficulties may be encountered in diagnosis. Materials and Methods: We retrospectively screened all B-cell lymphoma patients. Then, patients, who had been diagnosed without gastrointestinal system biopsy, were excluded from the study. Demographic data for these patients was obtained from the hospital information system and outpatient clinic files. Slides of these patients were obtained from pathology archive and re-evaluated under light microscope by two pathologists. All cases were diagnosed in line with revised World Health Organization (WHO) 2017 classification. Results: Fifty-five patients were diagnosed with B-cell lymphoma via endoscopic or colonoscopic biopsies. Forty of these patients were diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL), ten with Marginal Zone Lymphoma (MZL), two with Mantle Cell Lymphoma (MCL), two with Burkitt Lymphoma (BL) and one patient with Lymphoplasmacytic Lymphoma (LPL). Conclusion: In line with the literature, in our study, the patients with GI tract diagnosis had the highest frequency of DLBCL. The second most common B-cell lymphoma was MALToma. Although the frequency of GI involvement is high in MCL, the number of patients, diagnosed with GI involvement was small. The reason for this was that the patients had been diagnosed on the basis of nodal involvement rather than GI biopsy.
- 23 June 2025
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 26 (2) , 136-143
Open AccessGastrointestinal Manifestations of Mature B Cell Neoplasms: Single Center Experiences from the Collective Perspective of Hematology and Pathology
Background/aim: Hematological malignancies frequently affect the gastrointestinal (GI) tract, either by secondary extranodal or extramedullary extension to the GI tract or as the primary process, developing in the GI tract. The prevalence of gastrointestinal non-Hodgkin’s lymphomas (gNHL) is smaller than other solid organ tumours of the GI tract. Therefore, in the absence of nodal or extranodal involvement in imaging methods, difficulties may be encountered in diagnosis. Materials and Methods: We retrospectively screened all B-cell lymphoma patients. Then, patients, who had been diagnosed without gastrointestinal system biopsy, were excluded from the study. Demographic data for these patients was obtained from the hospital information system and outpatient clinic files. Slides of these patients were obtained from pathology archive and re-evaluated under light microscope by two pathologists. All cases were diagnosed in line with revised World Health Organization (WHO) 2017 classification. Results: Fifty-five patients were diagnosed with B-cell lymphoma via endoscopic or colonoscopic biopsies. Forty of these patients were diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL), ten with Marginal Zone Lymphoma (MZL), two with Mantle Cell Lymphoma (MCL), two with Burkitt Lymphoma (BL) and one patient with Lymphoplasmacytic Lymphoma (LPL). Conclusion: In line with the literature, in our study, the patients with GI tract diagnosis had the highest frequency of DLBCL. The second most common B-cell lymphoma was MALToma. Although the frequency of GI involvement is high in MCL, the number of patients, diagnosed with GI involvement was small. The reason for this was that the patients had been diagnosed on the basis of nodal involvement rather than GI biopsy.
- 30 April 2021
- Published by Tip Egitimi Dunyasi in Tıp Eğitimi Dünyası
- Vol. 20 (60-1) , 72-77
COVID-19 Pandemisi Sürecinde Trakya Üniversitesi Tıp Fakültesi Mezuniyet Öncesi Tıp Eğitimi Uygulamaları
Küresel olarak yaşadığımız Covid-19 pandemisi sonucunda, dünyada ve ülkemizde tüm tıp fakültelerinde yüz yüze yapılan tüm teorik dersler ve uygulamalar sonlandırılmış, uzaktan eğitim, dijital eğitim olanakları ile verilmeye başlanmıştır. Fakültemizde 2019-2020 bahar döneminde derslerin büyük bir çoğunluğu asenkron olarak yapıldı. Pandemi ile üniversitelerde sınavların yüz yüze yapılmaması kararları doğrultusunda sınavlar, Trakya Üniversitesi Uzaktan Eğitim Merkezi ve Medu-Trakya üzerinden online (asenkron) olarak yapılmıştır. Ulusal çekirdek eğitim programı 2020 yayınlandıktan hemen sonra teorik derslerin ve uygulamaların düzenlenmesi, pandemi koşullarında derslerin yüz yüze, asenkron veya senkron olarak hangi oranlarda yapılacağı ilgili ders ve staj kurulları tarafından planlandı. Sonuç olarak, COVID-19 pandemisinin tıp fakülteleri mezunlarında bulunması gereken yetkinlikler ve yeterlikler üzerinde yeniden düşünme ihtiyacını ortaya çıkardığı kanısındayız. Ayrıca tıp fakültelerinde yüz yüze eğitimin önemi bir kez daha ortaya çıkarken, uzaktan eğitim olanaklarının da etkin bir şekilde kullanılabileceğinin deneyimlendiği düşüncesindeyiz. Buradan hareketle gelecekte normalleşme süreciyle birlikte tıp eğitimi programlarının gözden geçirilerek yeniden yapılandırılmak suretiyle farklı boyutlara taşınacağı öngörülebilir.
- 30 April 2021
- Published by Tip Egitimi Dunyasi in Tıp Eğitimi Dünyası
- Vol. 20 (60-1) , 72-77
COVID-19 Pandemisi Sürecinde Trakya Üniversitesi Tıp Fakültesi Mezuniyet Öncesi Tıp Eğitimi Uygulamaları
Küresel olarak yaşadığımız Covid-19 pandemisi sonucunda, dünyada ve ülkemizde tüm tıp fakültelerinde yüz yüze yapılan tüm teorik dersler ve uygulamalar sonlandırılmış, uzaktan eğitim, dijital eğitim olanakları ile verilmeye başlanmıştır. Fakültemizde 2019-2020 bahar döneminde derslerin büyük bir çoğunluğu asenkron olarak yapıldı. Pandemi ile üniversitelerde sınavların yüz yüze yapılmaması kararları doğrultusunda sınavlar, Trakya Üniversitesi Uzaktan Eğitim Merkezi ve Medu-Trakya üzerinden online (asenkron) olarak yapılmıştır. Ulusal çekirdek eğitim programı 2020 yayınlandıktan hemen sonra teorik derslerin ve uygulamaların düzenlenmesi, pandemi koşullarında derslerin yüz yüze, asenkron veya senkron olarak hangi oranlarda yapılacağı ilgili ders ve staj kurulları tarafından planlandı. Sonuç olarak, COVID-19 pandemisinin tıp fakülteleri mezunlarında bulunması gereken yetkinlikler ve yeterlikler üzerinde yeniden düşünme ihtiyacını ortaya çıkardığı kanısındayız. Ayrıca tıp fakültelerinde yüz yüze eğitimin önemi bir kez daha ortaya çıkarken, uzaktan eğitim olanaklarının da etkin bir şekilde kullanılabileceğinin deneyimlendiği düşüncesindeyiz. Buradan hareketle gelecekte normalleşme süreciyle birlikte tıp eğitimi programlarının gözden geçirilerek yeniden yapılandırılmak suretiyle farklı boyutlara taşınacağı öngörülebilir.
- Open Access
- 26 February 2019
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 36 (2) , 78-87
The Progress of Next Generation Sequencing in the Assessment of Myeloid Malignancies
The introduction and advances on next-generation sequencing have led to novel ways to integrate simultaneous assessment of multiple target genes in routine laboratory analysis. Assessment of myeloid neoplasms with targeted next-generation sequencing panels shows evidence to improve diagnosis, assist therapeutic decisions, provide better information about prognosis, and better detection of minimal residual disease. Herein, we provide information for application and utilization of next-generation sequencing studies with a focus on the most important mutations in acute myeloid leukemia, myelodysplastic syndrome, myeloproliferative neoplasms, and other myelodysplastic/myeloproliferative neoplasms in order to integrate them into the daily clinical practice.
- 26 February 2019
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 36 (2) , 78-87
Open AccessThe Progress of Next Generation Sequencing in the Assessment of Myeloid Malignancies
The introduction and advances on next-generation sequencing have led to novel ways to integrate simultaneous assessment of multiple target genes in routine laboratory analysis. Assessment of myeloid neoplasms with targeted next-generation sequencing panels shows evidence to improve diagnosis, assist therapeutic decisions, provide better information about prognosis, and better detection of minimal residual disease. Herein, we provide information for application and utilization of next-generation sequencing studies with a focus on the most important mutations in acute myeloid leukemia, myelodysplastic syndrome, myeloproliferative neoplasms, and other myelodysplastic/myeloproliferative neoplasms in order to integrate them into the daily clinical practice.
- Open Access
- 1 January 2019
- Published by LookUs Bilisim A.S. in Eastern Journal Of Medicine
- Vol. 24 (4) , 437-440
Retrospective Evaluation of Patients with Hairy Cell Leukemia: A Decade Experience at a Single Center
- 1 January 2019
- Published by LookUs Bilisim A.S. in Eastern Journal Of Medicine
- Vol. 24 (4) , 437-440
Open AccessRetrospective Evaluation of Patients with Hairy Cell Leukemia: A Decade Experience at a Single Center
- 24 September 2018
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
The Progress of Next Generation Sequencing in Assessment of Myeloid Malinancies
With increasing characterization of disease associated molecular markers, it is becoming challenging to perform multiple single-gene molecular assays. Specific molecular markers are helpful for diagnostic, prognostic evaluation and management of hematologic malignancies. Introduction and rapid progress on next generation sequencing has led to extensive modifications and offers a novel way to integrate concurrent assessment of multiple target genes in routine laboratory analysis especially in view of increasing clinical demands for testing of multiple genetic aberrations. Despite challenges in next generation sequencing particularly involving bioinformatics support and clinical annotation of novel variants, assessment of myeloid neoplasms with targeted next generation sequencing panels showing evidence to improve diagnosis, assist therapeutic decisions and provide better information about prognosis, as well as detection of minimal residual disease since it facilitates significant advantages over single-gene assays. Herein, we provide information for application and utilization of next generation sequencing studies with a focus on the most important mutations in clinical assessment of hematologic neoplasms such as acute myeloid leukemia, myelodysplastic syndrome, myeloproliferative neoplasms and other myelodysplastic/myeloproliferative neoplasms in order to integrate into daily clinical practice.
- 24 September 2018
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
The Progress of Next Generation Sequencing in Assessment of Myeloid Malinancies
With increasing characterization of disease associated molecular markers, it is becoming challenging to perform multiple single-gene molecular assays. Specific molecular markers are helpful for diagnostic, prognostic evaluation and management of hematologic malignancies. Introduction and rapid progress on next generation sequencing has led to extensive modifications and offers a novel way to integrate concurrent assessment of multiple target genes in routine laboratory analysis especially in view of increasing clinical demands for testing of multiple genetic aberrations. Despite challenges in next generation sequencing particularly involving bioinformatics support and clinical annotation of novel variants, assessment of myeloid neoplasms with targeted next generation sequencing panels showing evidence to improve diagnosis, assist therapeutic decisions and provide better information about prognosis, as well as detection of minimal residual disease since it facilitates significant advantages over single-gene assays. Herein, we provide information for application and utilization of next generation sequencing studies with a focus on the most important mutations in clinical assessment of hematologic neoplasms such as acute myeloid leukemia, myelodysplastic syndrome, myeloproliferative neoplasms and other myelodysplastic/myeloproliferative neoplasms in order to integrate into daily clinical practice.
- Open Access
- 29 August 2018
- Published by Maad Rayan Publishing Company in Hospital Practices and Research
- Vol. 3 (4) , 137-139
Hypereosinophilic Cardiac Involvement Presenting With Left Ventricular Massive Thrombus and Cardioembolic Stroke: A Case Report
Introduction: It is well known that the tendency toward thrombosis is increased in cancer patients. The increase in cancer procoagulant and tissue factor levels, endothelial damage, and stasis due to compression are among the most accused causes of thrombosis in cancer patients. Hypereosinophilia is a rare condition that causes endothelial damage leading to thrombosis. Case Presentation: We present a 64-year-old male patient with cardiac involvement of hypereosinophilia which developed in the T-cell lymphoma ground resulting in a fatal cardioembolic stroke. Despite normal left ventricular (LV) contractions, almost half of the ventricular volume was full of thrombus in this case. Conclusion: Hypereosinophilia is a rare cause of thrombus formation in the left ventricle in patients with preserved ejection fraction. However, hypereosinophilic cardiac involvement can lead to rapid, progressive, life-threatening complications.
- 29 August 2018
- Published by Maad Rayan Publishing Company in Hospital Practices and Research
- Vol. 3 (4) , 137-139
Open AccessHypereosinophilic Cardiac Involvement Presenting With Left Ventricular Massive Thrombus and Cardioembolic Stroke: A Case Report
Introduction: It is well known that the tendency toward thrombosis is increased in cancer patients. The increase in cancer procoagulant and tissue factor levels, endothelial damage, and stasis due to compression are among the most accused causes of thrombosis in cancer patients. Hypereosinophilia is a rare condition that causes endothelial damage leading to thrombosis. Case Presentation: We present a 64-year-old male patient with cardiac involvement of hypereosinophilia which developed in the T-cell lymphoma ground resulting in a fatal cardioembolic stroke. Despite normal left ventricular (LV) contractions, almost half of the ventricular volume was full of thrombus in this case. Conclusion: Hypereosinophilia is a rare cause of thrombus formation in the left ventricle in patients with preserved ejection fraction. However, hypereosinophilic cardiac involvement can lead to rapid, progressive, life-threatening complications.
- Open Access
- 1 May 2018
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 34 (2) , 134-142
BRAF V600 Mutation Profile of Metastatic Melanoma in the Thrace Region of Turkey
Objective: BRAF is the most common mutation in melanoma. The most common subtype is BRAF V600E, followed by V600K. Initially, the authors aimed to investigate whether clinicopathological features of melanoma are associated with BRAF mutations. We then aimed to present the relationships between the clinicopathological features and the mutated subtype (V600E vs V600K). Material and Method: 61 patients with metastatic malignant melanoma (affecting the lymph node or other distant sites) were selected. Patient data regarding age at the time of diagnosis, sex, metastatic site (lymph node, distant metastasis or both) and primary tumour site were obtained from the hospital's database. Tissue samples containing at least 30% tumour cells were isolated from the specimens of 61 patients (24 samples from primary tumours and 37 from metastatic foci) for BRAF analysis. Comparisons between the BRAF V600 mutation and clinicopathological and histopathological features were performed. Results: BRAF V600 mutation was detected in 34 (55.7%) patients. The subtype was BRAF V600E in 22 (64.7%) patients, BRAF V600K in 11(32.4%) patients and BRAF V600R in 1(2.9%) patient. The crucial results of the present study may be summarized as follows: i) BRAF V600 mutation was more common in older patients and tumors with BRAF V600 mutation revealed necrosis and LVI more commonly than wild-type tumors, ii) BRAF V600K mutation was more common in older patients and BRAF V600K mutated tumors exhibited ulceration more commonly than tumors with BRAF V600E mutation (close to significant). Conclusion: The BRAF V600 mutation may have interactions with prognostic clinicoptahological features of melanoma including necrosis and lymphovascular invasion. V600K mutation may be more common than expected and may have different associations with properties of the tumor such as tumor ulceration and patient age. Investigation of the mutated subtype of the BRAF gene may therefore reveal more detailed data about the management of melanoma and may also prevent missing of candidates for BRAF inhibitor therapies.
- 1 May 2018
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 34 (2) , 134-142
Open AccessBRAF V600 Mutation Profile of Metastatic Melanoma in the Thrace Region of Turkey
Objective: BRAF is the most common mutation in melanoma. The most common subtype is BRAF V600E, followed by V600K. Initially, the authors aimed to investigate whether clinicopathological features of melanoma are associated with BRAF mutations. We then aimed to present the relationships between the clinicopathological features and the mutated subtype (V600E vs V600K). Material and Method: 61 patients with metastatic malignant melanoma (affecting the lymph node or other distant sites) were selected. Patient data regarding age at the time of diagnosis, sex, metastatic site (lymph node, distant metastasis or both) and primary tumour site were obtained from the hospital's database. Tissue samples containing at least 30% tumour cells were isolated from the specimens of 61 patients (24 samples from primary tumours and 37 from metastatic foci) for BRAF analysis. Comparisons between the BRAF V600 mutation and clinicopathological and histopathological features were performed. Results: BRAF V600 mutation was detected in 34 (55.7%) patients. The subtype was BRAF V600E in 22 (64.7%) patients, BRAF V600K in 11(32.4%) patients and BRAF V600R in 1(2.9%) patient. The crucial results of the present study may be summarized as follows: i) BRAF V600 mutation was more common in older patients and tumors with BRAF V600 mutation revealed necrosis and LVI more commonly than wild-type tumors, ii) BRAF V600K mutation was more common in older patients and BRAF V600K mutated tumors exhibited ulceration more commonly than tumors with BRAF V600E mutation (close to significant). Conclusion: The BRAF V600 mutation may have interactions with prognostic clinicoptahological features of melanoma including necrosis and lymphovascular invasion. V600K mutation may be more common than expected and may have different associations with properties of the tumor such as tumor ulceration and patient age. Investigation of the mutated subtype of the BRAF gene may therefore reveal more detailed data about the management of melanoma and may also prevent missing of candidates for BRAF inhibitor therapies.